| Spiriva Observational Study Measuring Saint George's Respiratory Questionnaire (SGRQ) in Routine Medical Practice in Central & Eastern European Region (NCT01006135) | Boehringer Ingelheim | 2009-10-01 |
| Pulmonary Function, Chronic Obstructive Pulmonary Disease (COPD) Prevalence, and Systemic Inflammation in Chronic Heart Failure With or Without COPD (NCT01429376) | Rijnstate Hospital | 2009-10-01 |
| BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate) (NCT00929851) | Chiesi Farmaceutici S.p.A. | 2009-10-01 |
| Antibiotics in Chronic Obstructive Pulmonary Disease (COPD) (NCT00952861) | Odense University Hospital | 2009-10-01 |
| A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01017952) | GlaxoSmithKline | 2009-09-25 |
| A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01009463) | GlaxoSmithKline | 2009-09-25 |
| High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD) (NCT00990119) | Vapotherm, Inc. | 2009-09-01 |
| Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers (NCT00984906) | Orion Corporation, Orion Pharma | 2009-09-01 |
| GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease (NCT00950807) | GlaxoSmithKline | 2009-09-01 |
| Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01381471) | GlaxoSmithKline | 2009-08-01 |
| Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone) (NCT01332409) | GlaxoSmithKline | 2009-08-01 |
| Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT00961038) | Bayer | 2009-08-01 |
| Assessment of Treatment With PulseHaler on Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00821418) | Respinova LTD | 2009-08-01 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of GSK573719 (LAMA) and GW642444 (LABA)Administered Individually and Concurrently in Healthy Japanese Subjects (NCT00976144) | GlaxoSmithKline | 2009-07-29 |
| Prophylactic Efficacy of Relenza Against Influenza A and B (NCT01156701) | GlaxoSmithKline | 2009-07-01 |
| Effect of Educational Intervention in Patients With Low-Risk Chronic Obstructive Pulmonary Disease (NCT00932711) | VA Midwest Health Care Network | 2009-07-01 |
| Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease (NCT00931385) | Boehringer Ingelheim | 2009-06-01 |
| Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease (NCT00932646) | Boehringer Ingelheim | 2009-06-01 |
| Actuation Indicator Trial in Patients With COPD (NCT00928746) | Boehringer Ingelheim | 2009-06-01 |
| European Quality of Care Pathways Study on Chronic Obstructive Pulmonary Disease (COPD) (NCT00962468) | European Pathway Association | 2009-05-01 |
| Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers (NCT00920660) | GlaxoSmithKline | 2009-04-06 |
| A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (NCT00862641) | Astellas Pharma Inc | 2009-04-01 |
| A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00857766) | GlaxoSmithKline | 2009-03-01 |
| Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting (NCT01013948) | GlaxoSmithKline | 2009-02-01 |
| Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I (NCT00793624) | Boehringer Ingelheim | 2009-02-01 |
| Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease (NCT00975195) | Boehringer Ingelheim | 2009-02-01 |
| BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD (NCT00846768) | Boehringer Ingelheim | 2009-02-01 |
| 12 / 48 wk Pivotal PFT vs PBO in COPD II (NCT00782509) | Boehringer Ingelheim | 2009-02-01 |
| Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD (NCT00824382) | Boehringer Ingelheim | 2009-01-01 |
| Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II (NCT00796653) | Boehringer Ingelheim | 2009-01-01 |
| The London COPD Exacerbation Cohort (NCT02755974) | Imperial College London | 2009-01-01 |
| Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels (NCT00851370) | National Jewish Health | 2009-01-01 |
| Drug Interaction Study to Investigate Co-administration of GW642444M With Ketoconazole (NCT00866515) | GlaxoSmithKline | 2008-12-22 |
| Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy (NCT00791518) | GlaxoSmithKline | 2008-12-01 |
| A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD). (NCT00784550) | GlaxoSmithKline | 2008-12-01 |
| Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD (NCT00749411) | GlaxoSmithKline | 2008-11-13 |
| A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects (NCT00783003) | GlaxoSmithKline | 2008-11-10 |
| 12 / 48 Week Pivotal PFT vs PBO in COPD I (NCT00782210) | Boehringer Ingelheim | 2008-11-01 |
| A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection (NCT00711126) | GlaxoSmithKline | 2008-10-21 |
| Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients. (NCT00783406) | Pfizer | 2008-10-01 |
| A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days (NCT00732472) | GlaxoSmithKline | 2008-10-01 |
| Phase I Study of GSK233705 in Healthy Japanese Male Subjects (NCT00964405) | GlaxoSmithKline | 2008-09-20 |
| Phase I Study of GW642444M in Healthy Japanese Male Subjects (NCT00964249) | GlaxoSmithKline | 2008-09-20 |
| Real-Time Telehealth to Promote Self-care Management for Chronic Obstructive Pulmonary Disease (NCT01161290) | Breathe California, Los Angeles County | 2008-09-01 |
| Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction (NCT00871637) | University of Nebraska | 2008-08-01 |
| A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD) (NCT00731822) | GlaxoSmithKline | 2008-08-01 |
| Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension. (NCT00640315) | Bayer | 2008-08-01 |
| Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis (NCT00726479) | Boehringer Ingelheim | 2008-08-01 |
| Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00720499) | Boehringer Ingelheim | 2008-07-01 |
| Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations (NCT01381406) | GlaxoSmithKline | 2008-07-01 |
| Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis (NCT00690885) | Ainos, Inc. (f/k/a Amarillo Biosciences Inc. | 2008-06-01 |
| Observational Non-Interventional Study With Spiriva Respimat in COPD Patients (NCT00699699) | Boehringer Ingelheim | 2008-06-01 |
| Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) (NCT02231177) | Boehringer Ingelheim | 2008-06-01 |
| Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677 (NCT00694902) | GlaxoSmithKline | 2008-05-26 |
| A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects. (NCT00671216) | GlaxoSmithKline | 2008-05-20 |
| Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00676052) | GlaxoSmithKline | 2008-05-16 |
| A Healthy Volunteer Study With Inhaled GSK573719 and Placebo (NCT00803673) | GlaxoSmithKline | 2008-05-05 |
| Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00671073) | Forest Laboratories | 2008-05-05 |
| Tiotropium and Salmeterol PK Study in COPD Patients (NCT00673478) | Boehringer Ingelheim | 2008-05-01 |
| A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients (NCT00702910) | GlaxoSmithKline | 2008-04-27 |
| Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD (NCT00662792) | Boehringer Ingelheim | 2008-04-15 |
| Tiotropium/Salmeterol Inhalation Powder in COPD (NCT00668772) | Boehringer Ingelheim | 2008-04-15 |
| An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs. (NCT00674817) | Theravance Biopharma | 2008-04-01 |
| Repeat Dose Study in Male Healthy Volunteer Smokers (NCT00615576) | GlaxoSmithKline | 2008-03-26 |
| PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT00683722) | Mesoblast, Inc. | 2008-03-20 |
| A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers (NCT00687700) | Theravance Biopharma | 2008-03-10 |
| Community Based Self Management of COPD Facilitated by a Palliative Care Team:Impact on Health Care Utilization and QOL (NCT00648609) | Essentia Health | 2008-03-01 |
| Advair HFA For Chronic Obstructive Pulmonary Disease(COPD) (NCT00633217) | GlaxoSmithKline | 2008-03-01 |
| A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00642148) | GlaxoSmithKline | 2008-02-14 |
| Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease (NCT00601055) | Weill Medical College of Cornell University | 2008-02-01 |
| A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00606684) | GlaxoSmithKline | 2008-02-01 |
| Family-supported Smoking Cessation for Chronically Ill Veterans (NCT00448344) | US Department of Veterans Affairs | 2008-02-01 |
| To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males (NCT00599612) | GlaxoSmithKline | 2008-01-17 |
| Venovenous CO2 Removal (VVCO2R) in Patients With COPD and Acute Respiratory Failure (NCT00594009) | The University of Texas Medical Branch, Galveston | 2008-01-01 |
| Osteoprotegerin (OPG) in Induced Chronic Obstructive Pulmonary Disease (COPD) Sputum (NCT00655954) | Imperial College London | 2008-01-01 |
| Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients. (NCT00563381) | Boehringer Ingelheim | 2008-01-01 |
| Effect of GSK1160724 In Healthy Volunteers (NCT00555022) | GlaxoSmithKline | 2007-12-12 |
| Association Between Increased Oxidative Stress, Anti-Inflammatory Fatty Acid Formation, and Airway Infection in People With Asthma and Chronic Obstructive Pulmonary Disease (NCT00595114) | Brigham and Women's Hospital | 2007-12-01 |
| Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice (NCT00624377) | Boehringer Ingelheim | 2007-12-01 |
| Succinate Salt Version of GSK961081 for Healthy Volunteers (NCT00550225) | Theravance Biopharma | 2007-11-29 |
| Feedback Reports and e-Learning in Primary Care Spirometry (NCT00962455) | Radboud University Medical Center | 2007-11-01 |
| Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease (NCT00725309) | Washington University School of Medicine | 2007-11-01 |
| Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) (NCT00608764) | Brigham and Women's Hospital | 2007-11-01 |
| Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV (NCT00527826) | GlaxoSmithKline | 2007-11-01 |
| Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients (NCT00680056) | Federal University of São Paulo | 2007-11-01 |
| Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone (NCT00551811) | GlaxoSmithKline | 2007-10-08 |
| Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00549679) | GlaxoSmithKline | 2007-10-04 |
| Factors That Affect the Development of COPD Symptoms (NCT00740337) | Washington University School of Medicine | 2007-10-01 |
| Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD (NCT00535366) | Boehringer Ingelheim | 2007-10-01 |
| Endotoxin Challenge Study For Healthy Men and Women (NCT00515268) | GlaxoSmithKline | 2007-09-27 |
| To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]SB-681323 in Healthy Adult Males (NCT00564746) | GlaxoSmithKline | 2007-09-20 |
| An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. (NCT00528996) | Boehringer Ingelheim | 2007-09-06 |
| Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD (NCT00530842) | Boehringer Ingelheim | 2007-09-01 |
| Effect of GSK704838 In Healthy Volunteers (NCT00539825) | GlaxoSmithKline | 2007-09-01 |
| Optimising the Propranolol Block Model (NCT00549120) | GlaxoSmithKline | 2007-08-15 |
| Transforming Psychotherapy for Chronically Ill Patients (NCT00520429) | US Department of Veterans Affairs | 2007-08-01 |
| Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD) (NCT00549445) | University of Alabama at Birmingham | 2007-08-01 |
| Tiotropium In Exercise (NCT00525512) | Boehringer Ingelheim | 2007-08-01 |
| A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients. (NCT00519376) | GlaxoSmithKline | 2007-08-01 |
| A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT00500318) | AstraZeneca | 2007-07-01 |